Leadership Overview
Santa Farma has 6 executives leading key functions including strategy, administrative support, financial oversight, marketing operations, quality assurance, and business development.
Driven by a commitment to pharmaceutical excellence, Santa Farma advances healthcare standards through modern manufacturing and multinational collaborations while maintaining a deep respect for society and professional development.
Driven by a commitment to pharmaceutical excellence, Santa Farma advances healthcare standards through modern manufacturing and multinational collaborations while maintaining a deep respect for society and professional development.
Leadership Roles at Santa Farma
Sami Kiresepi - Chief Executive Officer
Sami Kiresepi, the Chief Executive Officer at Santa Farma, directs the overarching strategic vision for the organization. Overseeing the integration of modern manufacturing techniques, the Chief Executive Officer ensures that pharmaceutical production meets rigorous international standards. This leadership role involves fostering multinational collaborations to expand the reach of the company within the competitive healthcare sector. By prioritizing rational strength and sensitivity to people, Sami Kiresepi guides the executive team toward sustainable growth and operational excellence. The Chief Executive Officer maintains alignment with the core mission of providing high-quality medications to healthcare professionals across the region. Through constant evaluation of market trends, the Chief Executive Officer secures the long-term stability of the firm. This executive leadership ensures that the company remains a trusted partner in the pharmaceutical industry, consistently delivering value to patients and stakeholders while upholding the highest ethical standards in every business endeavor.
Jaklin Demirci - Chief Executive Officer Asistanı
Jaklin Demirci, the Chief Executive Officer Asistanı at Santa Farma, manages critical administrative workflows and executive communications. Coordinating daily operations for the leadership team, the Chief Executive Officer Asistanı ensures that strategic initiatives receive the necessary support for successful execution. This role involves streamlining internal processes to enhance organizational efficiency and communication across departments. By facilitating collaboration between the executive office and various functional units, Jaklin Demirci maintains the operational rhythm required for complex pharmaceutical projects. The Chief Executive Officer Asistanı monitors project timelines and ensures that administrative tasks align with the broader corporate objectives of the firm. Through meticulous attention to detail, the Chief Executive Officer Asistanı supports the executive decision-making process, allowing for rapid responses to industry shifts. This position remains vital for maintaining the professional standards and organizational integrity that define the company within the Turkish healthcare market.
Esra Atış - Director, Finance & Chief Financial Officer
Esra Atış, the Director, Finance & Chief Financial Officer at Santa Farma, manages the fiscal health and capital allocation strategies of the organization. Overseeing financial reporting, budgeting, and investment analysis, the Director, Finance & Chief Financial Officer ensures that resources support the company's commitment to modern manufacturing and pharmaceutical innovation. This leadership role involves maintaining transparency with stakeholders and optimizing the cost structure to drive profitability. By analyzing market data, Esra Atış provides the insights necessary for the executive team to make informed decisions regarding expansion and multinational partnerships. The Director, Finance & Chief Financial Officer monitors cash flow and risk management to protect the financial stability of the firm. Through rigorous financial planning, the Director, Finance & Chief Financial Officer supports the long-term growth objectives of the company, ensuring that every investment aligns with the core values of rational strength and professional excellence in the healthcare sector.
Tugce Bespinar - Chief Marketing Officer, Contract Manufacturing Operations Transfer & Quality Assurance Specialist
Tugce Bespinar, the Chief Marketing Officer, Contract Manufacturing Operations Transfer & Quality Assurance Specialist at Santa Farma, directs the commercial strategy for contract manufacturing services. Overseeing the transfer of complex operations, the Chief Marketing Officer, Contract Manufacturing Operations Transfer & Quality Assurance Specialist ensures that all processes adhere to strict quality assurance protocols. This role involves building relationships with healthcare professionals and partners to expand the market presence of the company. By integrating quality control into the marketing narrative, Tugce Bespinar demonstrates the reliability of the manufacturing services offered. The Chief Marketing Officer, Contract Manufacturing Operations Transfer & Quality Assurance Specialist coordinates with technical teams to ensure that every product meets the high standards expected by the industry. Through strategic market positioning, the Chief Marketing Officer, Contract Manufacturing Operations Transfer & Quality Assurance Specialist drives the growth of the contract manufacturing division, ensuring that the company remains a leader in pharmaceutical production and quality assurance.
Eda Alamış - Chief Marketing Officer, Quality Projects & Manager, Validation
Eda Alamış, the Chief Marketing Officer, Quality Projects & Manager, Validation at Santa Farma, leads the strategic marketing of quality-focused initiatives and validation services. Overseeing the validation of manufacturing processes, the Chief Marketing Officer, Quality Projects & Manager, Validation ensures that all pharmaceutical outputs comply with regulatory requirements and internal quality benchmarks. This role involves communicating the value of rigorous validation procedures to healthcare professionals and external partners. By managing quality projects, Eda Alamış enhances the reputation of the company as a provider of safe and effective medications. The Chief Marketing Officer, Quality Projects & Manager, Validation collaborates with cross-functional teams to ensure that marketing efforts reflect the technical precision of the firm. Through the implementation of advanced validation strategies, the Chief Marketing Officer, Quality Projects & Manager, Validation supports the overall mission of delivering high-quality healthcare solutions, ensuring that the company maintains its competitive edge through superior quality management and transparent communication.
Derya Arslan - Business Development Manager & Chief Marketing Officer, Alliance Management)
Derya Arslan, the Business Development Manager & Chief Marketing Officer, Alliance Management) at Santa Farma, directs the identification and cultivation of new business opportunities. Overseeing alliance management, the Business Development Manager & Chief Marketing Officer, Alliance Management) ensures that multinational collaborations remain productive and aligned with the strategic goals of the firm. This role involves negotiating partnerships that expand the product portfolio and market reach of the company. By analyzing industry trends, Derya Arslan identifies gaps in the healthcare market that the company can address through its manufacturing capabilities. The Business Development Manager & Chief Marketing Officer, Alliance Management) coordinates with the executive team to integrate new alliances into the existing business model. Through proactive relationship management, the Business Development Manager & Chief Marketing Officer, Alliance Management) drives revenue growth and strengthens the position of the company as a key player in the pharmaceutical industry, ensuring that all partnerships reflect the core values of the organization.
Explore Leadership Teams in Manufacturing
Fresenius Kabi, a subsidiary of Fresenius, is a global health care company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is headquartered in Bad Homburg, Germany with locations around the world.
Company Leadership AR
RP
CM
RT
Bausch Health Companies Inc. operates as a global pharmaceutical and healthcare products company focused on developing, manufacturing, and marketing a broad portfolio of branded pharmaceuticals, generic medicines, over-the-counter healthcare products, and medical devices. The organization works to improve patient health outcomes by delivering therapeutic solutions across multiple medical specialties. Through its research, development, and commercial operations, the company serves healthcare providers, hospitals, pharmacies, and patients across numerous international markets. The company functions as a diversified healthcare enterprise with business segments that address several therapeutic and medical device categories. Its core focus areas include gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and ophthalmology. By maintaining a broad therapeutic portfolio, the organization supports healthcare professionals in diagnosing, managing, and treating a wide range of medical conditions that affect millions of patients globally.
Company Leadership
TU

Founded in 1973 and headquartered in Bangalore, India, Micro Lab is a pharmaceutical manufacturer, wholesaler, and R&D company.
Company Leadership MH
JL
RK
PM
Telix Pharmaceuticals is a global, commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, publicly listed on the Australian Securities Exchange and Nasdaq under the ticker TLX. The company specializes in the development and commercialization of diagnostic and therapeutic radiopharmaceuticals, commonly referred to as theranostics, which use molecularly targeted radiation to both image and treat cancer. Telix's pipeline is focused on urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. Its lead commercial product, Illuccix, is an approved PSMA-PET/CT imaging agent for prostate cancer with regulatory clearance from the FDA, Australia's TGA, and Health Canada.
Company Leadership KR

MD
